To the Editor Wunderink et al1 studied the long-term effects of early dosage reduction or discontinuation (DR) of antipsychotic medication vs maintenance treatment (MT) on recovery in patients with remitted first-episode psychosis. It makes an important contribution to the literature and has intriguing clinical implications. However, we would like to clarify some issues before concluding the longitudinal benefits of DR over MT in the study.